Home » Topics » Disease categories and therapies » Urology

Urology
RSS

VS-505 effective and well tolerated hyperphosphatemia treatment for hemodialysis patients

Nov. 3, 2017

Cara Therapeutics doses first patient in study of CR-845

Oct. 26, 2017

FDA issues complete response letter for Xyosted

Oct. 23, 2017

Cara Therapeutics planning phase III pivotal program for CR-845

Oct. 17, 2017

Japan Tobacco enters licensing agreement for Rayaldee in Japan

Oct. 16, 2017

Vantia reports phase III topline data on fedovapagon for nocturia in men with BPH

Oct. 5, 2017

Soluble Nogo-B a potential treatment for diabetic glomerulopathy

Oct. 5, 2017

COLEC11, a possible therapeutic target for treating renal ischemia reperfusion injury

Oct. 2, 2017

First subject enrolled in phase III study of TRC-101 in chronic kidney disease

Sep. 29, 2017

The Brigham and Women's Hospital identifies SMOC2 inhibitors

Sep. 26, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Menstrual ‘footprints’ may act as broad personal health markers
BioWorld
WAVES, an algorithm designed to extract menstrual-cycle metrics from physiological signals such as basal body temperature, which oscillates with sex hormones,...